Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
267 words
A compound of formula ##STR4## in which R 1 represents benzofurazanyl or phenyl, the phenyl being substituted by one or more of the groups halogen, nitro, --CN, --OR 9 , --S(O) p R 9 , or alkyl C 1 to C 6 optionally substituted by halogen, p is 0, 1 or 2, R.sub. 2 and R 3 , which may be the same or different, each represent hydrogen; alkyl C 1 to C 6 optionally substituted by one or more of the groups halogen, cyano, --XR 4 , --NR 5 R 6 or phenyl; cycloalkyl C 3 to C 8 optionally substituted by alkyl C 1 to C 6 ; an oxetanyl, azetidinyl, piperidinyl or tetrahydropyranyl ring which is optionally substituted by alkyl C 1 to C 6 , the alkyl in turn optionally being substituted by one or more phenyl groups; R 5 and R 6 , which may be the same or different, each represent alkyl C 1 to C 6 optionally substituted by phenyl, Y and Z together form a bond, one of R 7 and R 8 represents alkyl C 1 to C 6 and the other represents phenyl, X is O or S, R 4 is alkyl C 1 to C 6 or phenyl, and R 9 is alkyl C 1 to C 6 , provided that when R 7 is alkyl C 1 to C 6 , R 1 represents 3-nitrophenyl and R 2 and R 3 are both ethyl, then R 8 does not represent phenyl, and pharmaceutically acceptable acid addition salts of those compounds containing a basic nitrogen atom.
Claim 2
Dependent Claim
267 words
A compound of formula ##STR4## in which R 1 represents benzofurazanyl or phenyl, the phenyl being substituted by one or more of the groups halogen, nitro, --CN, --OR 9 , --S(O) p R 9 , or alkyl C 1 to C 6 optionally substituted by halogen, p is 0, 1 or 2, R.sub. 2 and R 3 , which may be the same or different, each represent hydrogen; alkyl C 1 to C 6 optionally substituted by one or more of the groups halogen, cyano, --XR 4 , --NR 5 R 6 or phenyl; cycloalkyl C 3 to C 8 optionally substituted by alkyl C 1 to C 6 ; an oxetanyl, azetidinyl, piperidinyl or tetrahydropyranyl ring which is optionally substituted by alkyl C 1 to C 6 , the alkyl in turn optionally being substituted by one or more phenyl groups; R 5 and R 6 , which may be the same or different, each represent alkyl C 1 to C 6 optionally substituted by phenyl, Y and Z together form a bond, one of R 7 and R 8 represents alkyl C 1 to C 6 and the other represents phenyl, X is O or S, R 4 is alkyl C 1 to C 6 or phenyl, and R 9 is alkyl C 1 to C 6 , provided that when R 7 is alkyl C 1 to C 6 , R 1 represents 3-nitrophenyl and R 2 and R 3 are both ethyl, then R 8 does not represent phenyl, and pharmaceutically acceptable acid addition salts of those compounds containing a basic nitrogen atom.
Claim 3
Dependent Claim
37 words
A compound according to claim 1, in which R 1 is 4-benzofurazanyl, or phenyl substituted by nitro, chloro or --CF 3 , and R 2 and R 3 are each alkyl C 1 to C 3 .
Claim 4
Dependent Claim
25 words
A compound according to claim 1 and selected from Diethyl 1,4-dihydro-2-methyl-6-phenyl-4-(2-(trifluoromethyl)phenyl)-3,5-pyridinedicarboxylate, 5-Methyl 3-(1-methylethyl) 4-(4-benzofurazanyl)1,4-dihydro-2-methyl-6-phenyl-3, 5-pyridinedicarboxylate, 5-methyl 3-(1-methylethyl) 1,4-dihydro-2-methyl-6phenyl-4-(2-(trifluoromethyl)phenyl)-3,5-pyridinedicarboxylate, 3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2-methyl-6-phenyl-3,5-pyridinedicarboxylate, and 5-Methyl 3-(1-methylethyl) 1,4-dihydro-2-methyl-4-(3-nitrophenyl)-6-phenyl-3,5-pyridinedicarboxylate.
Claim 5
Dependent Claim
27 words
A compound according to claim 1, in which R 1 is phenyl carrying at least two substituents selected from chloro, fluoro, --CF 3 , methyl and nitro.
Claim 6
Dependent Claim
12 words
A compound according to claim 1, in which R 1 is benzofurazanyl.
Claim 7
Dependent Claim
42 words
A pharmaceutical formulation containing an amount of a compound according to claim 1 effective to treat renovascular, malignant or essential hypertension, pulmonary hypertension, vasospastic angina, chronic stable angina or congestive heart failure, in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier.
Claim 8
Dependent Claim
42 words
A method of treatment of renovascular, malignant or essential hypertension, pulmonary hypertension, vasospastic angina, chronic stable angina or congestive heart failure, which comprises administering an effective amount of a compound according to claim 1 to a patient suffering from such a condition.